Q1WB
PFE icon

Quest 10 Wealth Builders’s Pfizer PFE Stock Holding History

Quest 10 Wealth Builders’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.4K Buy
2,092
+141
+7% +$3.69K 0.04% 209
2026
Q1 		$54.8K Sell
1,951
-42
-2% -$1.12K 0.05% 195
2025
Q4 		$49.6K Buy
1,993
+1,702
+585% +$42.9K 0.04% 187
2025
Q3 		$7.42K Buy
291
+32
+12% +$790 0.01% 422
2025
Q2 		$6.28K Sell
259
-2
-0.8% -$47 0.01% 460
2025
Q1 		$6.62K Sell
261
-38
-13% -$994 0.01% 432
2024
Q4 		$7.94K Buy
+299
New +$8.11K 0.01% 429

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Quest 10 Wealth Builders's PFE Position: Q2 2026 in Review

Quest 10 Wealth Builders increased its Pfizer (PFE) stake by 7.2% in Q2 2026, buying an estimated $3.69K and bringing the position to 2,092 shares worth $50.4K. The position accounts for 0.04% of the portfolio, ranked #209.

Quest 10 Wealth Builders first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $54.8K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Quest 10 Wealth Builders held 2,092 shares of Pfizer worth $50.4K as of Q2 2026.
  • Quest 10 Wealth Builders bought 141 Pfizer shares in Q2 2026, an estimated $3.69K.
  • Pfizer made up 0.04% of Quest 10 Wealth Builders's portfolio in Q2 2026, its #209 holding.
  • Quest 10 Wealth Builders first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Quest 10 Wealth Builders's Pfizer position peaked at $54.8K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.